Kromnigon AB

Kromnigon is a biotech company focused on new technologies for multicolor microscopy (multiplex IHC). The company was founded 2015 by Per Fogelstrand and Ulf Yrlid. It all started by a joint research project at Gothenburg university, Sweden, regarding leukocyte involvement in endothelial repair. To say the least, the project was histologically challenging, and from frustration new ideas emerged of how to convert multiplex IHC from craftsmanship to reliable methods that can be performed by anyone in the lab. In 2021, Kromnigon secured funding to expand and is now established in the premises at AstraZeneca BioVentureHub in Gothenburg.

Per Fogelstrand

Co-founder & CEO

Ulf Yrlid

Co-founder & Technical Adviser

Associate Professor, Dep. of Microbiology & Immunology, University of Gothenburg.

Panagiota Georgoulia

Laboratory Manager, R&D Scientist


  • Private investment company that focuses on emerging growth companies. The teaming up with Kromnigon provides experience in contract manufacturing, logistics, financing, incorporation, and scale-up.

  • Västra Götalandsregionen (VGR) works to create a vivid and sustainable industry. The goal is job creation by entrepreneurship and corporate growth. VGR works toward this goal by helping companies with seed capital and free consulting.

Union Dental

c/o AstraZeneca R&D
Pepparedsleden 1
SE-43183 Mölndal


Shipping adress

c/o AstraZeneca R&D
Pepparedsleden 3
SE-431 83 Mölndal

© All rights reserved.
 Powered by Webgiant Webbyrå